Phillip Pang - 27 Sep 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Chief Medical Officer
Signature: /s/ Howard Horn, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 27 Sep 2021
Net transactions value: +$4,275
Form type: 4
Filing time: 29 Sep 2021, 17:00:13 UTC
Previous filing: 17 Sep 2021
Next filing: 07 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Options Exercise	$4,275	+5,000	+4.8%	$0.8550^*	109,277	27 Sep 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Employee Stock Option (Right to Buy)	Options Exercise	$0	-5,000	-21%	$0.000000	18,833	27 Sep 2021	Common Stock	5,000	$0.8550	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter.